The Novel Synthetic Peptide AESIS-1 Exerts a Preventive Effect on Collagen-Induced Arthritis Mouse Model via STAT3 Suppression
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Kim, Kyung Eun | - |
dc.contributor.author | Jeon, Suwon | - |
dc.contributor.author | Song, Jisun | - |
dc.contributor.author | Kim, Tae Sung | - |
dc.contributor.author | Jung, Min Kyung | - |
dc.contributor.author | Kim, Myun Soo | - |
dc.contributor.author | Park, Sunyoung | - |
dc.contributor.author | Park, Seung Beom | - |
dc.contributor.author | Park, Jeong Min | - |
dc.contributor.author | Park, Hyun Jeong | - |
dc.contributor.author | Cho, Daeho | - |
dc.date.accessioned | 2021-08-31T14:43:52Z | - |
dc.date.available | 2021-08-31T14:43:52Z | - |
dc.date.created | 2021-06-18 | - |
dc.date.issued | 2020-01-02 | - |
dc.identifier.issn | 1661-6596 | - |
dc.identifier.uri | https://scholar.korea.ac.kr/handle/2021.sw.korea/58362 | - |
dc.description.abstract | Rheumatoid arthritis (RA) is a chronic autoimmune disease that is associated with systemic inflammation and results in the destruction of joints and cartilage. The pathogenesis of RA involves a complex inflammatory process resulting from the action of various proinflammatory cytokines and, therefore, many novel therapeutic agents to block cytokines or cytokine-mediated signaling have been developed. Here, we tested the preventive effects of a small peptide, AESIS-1, in a mouse model of collagen-induced arthritis (CIA) with the aim of identifying a novel safe and effective biological for treating RA. This novel peptide significantly suppressed the induction and development of CIA, resulting in the suppression of synovial inflammation and cartilage degradation in vivo. Moreover, AESIS-1 regulated JAK/STAT3-mediated gene expression in vitro. In particular, the gene with the most significant change in expression was suppressor of cytokine signaling 3 (Socs3), which was enhanced 8-fold. Expression of the STAT3-specific inhibitor, Socs3, was obviously enhanced dose-dependently by AESIS-1 at both the mRNA and protein levels, resulting in a significant reduction of STAT3 phosphorylation in splenocytes from severe CIA mice. This indicated that AESIS-1 regulated STAT3 activity by upregulation of SOCS3 expression. Furthermore, IL-17 expression and the frequency of Th17 cells were considerably decreased by AESIS-1 in vivo and in vitro. Collectively, our data suggest that the novel synthetic peptide AESIS-1 could be an effective therapeutic for treating RA via the downregulation of STAT3 signaling. | - |
dc.language | English | - |
dc.language.iso | en | - |
dc.publisher | MDPI | - |
dc.subject | RHEUMATOID-ARTHRITIS | - |
dc.subject | DOUBLE-BLIND | - |
dc.subject | JAK INHIBITORS | - |
dc.subject | FUTURE | - |
dc.subject | INFLAMMATION | - |
dc.subject | PATHWAYS | - |
dc.subject | IL-6 | - |
dc.subject | DIFFERENTIATION | - |
dc.subject | RECOMMENDATIONS | - |
dc.subject | INTERLEUKIN-6 | - |
dc.title | The Novel Synthetic Peptide AESIS-1 Exerts a Preventive Effect on Collagen-Induced Arthritis Mouse Model via STAT3 Suppression | - |
dc.type | Article | - |
dc.contributor.affiliatedAuthor | Cho, Daeho | - |
dc.identifier.doi | 10.3390/ijms21020378 | - |
dc.identifier.scopusid | 2-s2.0-85077901635 | - |
dc.identifier.wosid | 000515380000008 | - |
dc.identifier.bibliographicCitation | INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, v.21, no.2 | - |
dc.relation.isPartOf | INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES | - |
dc.citation.title | INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES | - |
dc.citation.volume | 21 | - |
dc.citation.number | 2 | - |
dc.type.rims | ART | - |
dc.type.docType | Article | - |
dc.description.journalClass | 1 | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.relation.journalResearchArea | Biochemistry & Molecular Biology | - |
dc.relation.journalResearchArea | Chemistry | - |
dc.relation.journalWebOfScienceCategory | Biochemistry & Molecular Biology | - |
dc.relation.journalWebOfScienceCategory | Chemistry, Multidisciplinary | - |
dc.subject.keywordPlus | RHEUMATOID-ARTHRITIS | - |
dc.subject.keywordPlus | DOUBLE-BLIND | - |
dc.subject.keywordPlus | JAK INHIBITORS | - |
dc.subject.keywordPlus | FUTURE | - |
dc.subject.keywordPlus | INFLAMMATION | - |
dc.subject.keywordPlus | PATHWAYS | - |
dc.subject.keywordPlus | IL-6 | - |
dc.subject.keywordPlus | DIFFERENTIATION | - |
dc.subject.keywordPlus | RECOMMENDATIONS | - |
dc.subject.keywordPlus | INTERLEUKIN-6 | - |
dc.subject.keywordAuthor | rheumatoid arthritis | - |
dc.subject.keywordAuthor | collagen-induced arthritis | - |
dc.subject.keywordAuthor | peptide | - |
dc.subject.keywordAuthor | SOCS3 | - |
dc.subject.keywordAuthor | STAT3 | - |
dc.subject.keywordAuthor | Th17 cells | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
(02841) 서울특별시 성북구 안암로 14502-3290-1114
COPYRIGHT © 2021 Korea University. All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.